Specialty Data Descriptors
January 23, 2019
Data: Quantitative information. Numbers. Trends. All the good stuff.
Specialty pharmacy data: All data collected at the dispensary and through patient touchpoints relevant to a specialty medication, ranging from objective and subjective clinical outcomes and disease progression to pricing, payers and demographics.
Patient support program data: Data on specialty indications/treatments generated within a PSP. PSPs provide a self-contained setting for the collection of disease-specific clinician- and patient-reported data, as well as operational program data.
Real-world data: Data on a medication’s performance and cost-effectiveness in patients with real-life clinical profiles, as opposed to patients in clinical trials.
Real-world evidence: Evidence arising from the aggregation and interpretation of real-world data.
Outcomes-based agreements: Agreements between manufacturers and private/public payers in which the payer’s responsibility to cover the medication is based on its performance in the real world.
Predictive analytics: Using data to create projections enabling the clinical and economic management of patients and their therapeutic journey. Management of adherence and disease progression is a current focus in the industry